This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy

Professionals 203 Users Online

Periodic Fever Syndrome Market

Periodic Fever Syndrome Market: Global industry analysis and forecast 2016 - 2024

Periodic Fever Syndrome Market Segmented By Indication such as Hyperimmunoglobulinemia D Syndrome (HIDS), Familial Mediterranean Fever (FMF), TNF Receptor-Associated Periodic Syndrome (TRAPS) and Cryopyrin-Associated Periodic Syndrome (CAPS)

Market Overview

Periodic Fever Syndrome are autoinflammatory diseases which cause episodic illness and do not have an infectious cause. Periodic Fever Syndrome are genetic and are also present during childhood. It is defined by the various genetic defects testing, by the clinical features of the syndrome, the affected part of the body, age of the patient and the area of the world from where the patient belongs. Treatment is based on the understanding of the gene defect.

Despite similarities in symptoms, periodic fever syndrome has different patterns of inheritance, causes, length and frequency of ‘attacks.' Some of the chronic condition associated with Periodic Fever Syndrome includes Cryopyrin-associated periodic syndrome (CAPS), hyperimmunoglobulinemia D syndrome (HIDS), TNF receptor-associated periodic syndrome (TRAPS) and Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis Syndrome (PFAPA).

The symptoms of Periodic Fever Syndrome are cyclic in nature, coming and going, with the difference in severity.

Periodic Fever Syndrome affects many organs and tissues and has its own set of symptoms along with high temperature during attacks. Elevated serum levels of acute-phase reactants such as fibrinogen and serum amyloid A, leukocytosis and high level of erythrocyte sedimentation rate (ESR) are associated with periodic fever syndrome.

Diagnostic tools and genetic test are available for patients with periodic fever. For some conditions such as Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis Syndrome (PFAPA), no genetic test are available yet. Hereditary periodic fever syndromes (HPFSs) are rare and is characterized by short and recurrent attacks. These attacks undergo remission without the use of antibiotic, anti-inflammatory, or immunosuppressive treatment. The patient feels healthy and is back to its daily routine until the next episode of periodic fever occurs.

Previously, there was no approved medicine for the treatment of TNF Receptor-Associated Periodic Syndrome (TRAPS), Hyperimmunoglobulinemia D Syndrome (HIDS)/ Mevalonate Kinase Deficiency (MKD).

In September 2016, the US Food and Drug Administration (FDA) has granted Novartis’ ilaris (canakinumab) expanded use for the treatment of these three rare and distinct types of Periodic Fever Syndromes.Treatment with oral anti-inflammatory drugs, e.g. corticosteroids and non-steroidal anti-inflammatory drugs (NSAIDs), helps to control the symptoms but does not assist in the prevention of Periodic Fever Syndrome

Sample Report

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

Market Segmentation

Indication
  • Hyperimmunoglobulinemia D Syndrome (HIDS)
  • Familial Mediterranean Fever (FMF)
  • TNF Receptor-Associated Periodic Syndrome (TRAPS)
  • Cryopyrin-Associated Periodic Syndrome (CAPS)
  • Others
Treatment
  • Oral anti-inflammatory drugs (corticosteroid)
  • Non-steroidal anti-inflammatory drugs (NSAIDs)
  • Anti-TNF therapy
  • Statins
  • Others
End User
  • Hospitals
  • Retail pharmacy
Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

Regional Outlook

On the basis of geography, global periodic fever syndrome market is segmented into five key regions i.e. North America, Europe, Latin America, Asia-Pacific, and the Middle East & Africa. North America is expected to dominate the global Periodic Fever Syndrome Market due to high demand from U.S.

Market Research Methodology

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

Key Players

Some of the major players in global Periodic Fever Syndrome Market are Novartis AG, Simvastatin, Merck & Co., Inc., Swedish Orphan Biovitrum AB.

Prerna Shiv

Prerna Shiv
Client Partner

Let's Connect

Conect me to identify wining opportunities

Ask An Expert
I'm Available

The report covers exhaustive analysis on:

  • Periodic Fever Syndrome Market Segments
  • Periodic Fever Syndrome Market Dynamics
  • Historical Actual Market Size, 2013 - 2015
  • Periodic Fever Syndrome Market Size & Forecast 2016 to 2024
  • Periodic Fever Syndrome Market Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Periodic Fever Syndrome Market Drivers and Restraints

Regional analysis includes

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size Recent industry trends
  • Key Competition landscape
  • Strategies of key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance

- Companies Covered in This Report -

Google translate